# OnCo record jnj-90014496 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/jnj-90014496/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "jnj-90014496" ;
  schema:name "JNJ-90014496"@en ;
  schema:description "JNJ-90014496 is an experimental CAR-T cell therapy from Janssen Research & Development in phase 2 trials for hodgkin lymphoma and diffuse large B-cell lymphoma, aimed at CD19 and CD20."@en ;
  schema:url <https://onco.cc/drugs/jnj-90014496/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=JNJ-90014496> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "CAR-T cell therapy" ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/dlbcl/> ;
  onco:targets <https://onco.cc/targets/cd19/>, <https://onco.cc/targets/cd20/> ;
  onco:companies <https://onco.cc/companies/johnson-johnson/> ;
  onco:trials <https://onco.cc/trials/nct05421663/> .